Baicalein Attenuates Angiotensin II-Induced Cardiac Remodeling via Inhibition of AKT/mTOR, ERK1/2, NF-κB, and Calcineurin Signaling Pathways in Mice
Autor: | Ying Liu, Hui-Hua Li, Lina Song, Liqing Yu, Ai-Wu Wang, Yunlong Xia, Cui Tian, Xue Jiang, Qiu-Yue Han, Jie Miao, Hong-Xia Wang, Jie Du |
---|---|
Rok vydání: | 2014 |
Předmět: |
Male
medicine.medical_specialty Time Factors Calcineurin Inhibitors Inflammation Ventricular Function Left Proinflammatory cytokine chemistry.chemical_compound Internal medicine Renin–angiotensin system Internal Medicine medicine Animals Lipoxygenase Inhibitors Phosphorylation Protein kinase B PI3K/AKT/mTOR pathway Mitogen-Activated Protein Kinase 1 Mitogen-Activated Protein Kinase 3 Ventricular Remodeling business.industry Angiotensin II Myocardium TOR Serine-Threonine Kinases NF-kappa B Fibrosis Baicalein Enzyme Activation Mice Inbred C57BL Calcineurin Disease Models Animal Oxidative Stress Endocrinology Gene Expression Regulation chemistry Flavanones Hypertension Cytokines Hypertrophy Left Ventricular Inflammation Mediators medicine.symptom business Proto-Oncogene Proteins c-akt Signal Transduction |
Zdroj: | American Journal of Hypertension. 28:518-526 |
ISSN: | 1941-7225 0895-7061 |
Popis: | Background Baicalein, a specific lipoxygenase (LOX) inhibitor, has anti-inflammatory and antioxidant effects. However, the functional role of baicalein in angiotensin II (Ang II)-induced hypertension and cardiac remodeling remains unclear. Here we investigated the effect of baicalein on cardiac hypertrophy and fibrosis and the underlying mechanism. Methods Wild-type (WT) mice were injected with Ang II (1,200ng/kg/min) alone or together with 12/15-LOX inhibitor baicalein (25mg/kg) for 14 days. Histological examinations were performed on heart sections with hematoxylin and eosin, Masson's trichrome, wheat germ agglutinin staining, and immunohistochemistry. The messenger RNA (mRNA) expression of cytokines and protein levels were detected by real-time polymerase chain reaction (PCR) and western blot analysis respectively. Results Ang II infusion significantly increased blood pressure but decreased cardiac contractile function reflected by fractional shortening% and ejection fraction% compared with saline-treated mice. Moreover, Ang II infusion resulted in marked cardiac hypertrophy and fibrosis, promoted accumulation of macrophages and T cells, the expression of proinflammatory cytokines and malondialdehyde (MDA) production. However, these actions were markedly reversed by administration of baicalein in mice. Mechanistically, the protective effects of baicalein were associated with the inhibition of inflammation, oxidative stress, and multiple signaling pathways (AKT/mTOR, ERK1/2, nuclear factor-κB (NF-κB), and calcineurin) in the Ang II-treated mice. Conclusions This study demonstrates that baicalein can significantly ameliorate Ang II-induced hypertension and cardiac remodeling, and may be a novel therapeutic drug for prevention of hypertensive heart diseases. |
Databáze: | OpenAIRE |
Externí odkaz: |